5-Bromo-6-methylindolin-2-one

Catalog No.: 
ACZRWI458
CAS No.: 
557093-46-6
Molecular Formula: 
C9H8BrNO
Molecular Weight: 
226.07
5-Bromo-6-methylindolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$55.00In stockInquiry
250mg97%$80.00In stockInquiry
1g97%$207.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-6-methylindolin-2-one
IUPAC Name5-bromo-6-methylindolin-2-one
MDL No.MFCD15525650
Molecular FormulaC9H8BrNO
Molecular Weight226.07
SMILESO=C1NC2=C(C=C(Br)C(C)=C2)C1
InChI KeyUUYGDAWPONZNJF-UHFFFAOYSA-N
Synonym5-broMo-6-Methylindolin-2-one;5-Bromo-6-methyl-2,3-dihydro-1h-indol-2-one;2H-Indol-2-one, 5-bromo-1,3-dihydro-6-methyl-
CAS No.557093-46-6
PubChem CID10307991

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACZRWI458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCPK176 route compound structure diagram
    ACBCPK17656341-38-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZRWI458 route product structure diagram
    ACZRWI458557093-46-6In Stock
Inquiry

2. ACZRWI458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKSZQ125 route compound structure diagram
    ACKSZQ12593556-88-8In Stock
  2. Plus
  3. ACBCPK176 route compound structure diagram
    ACBCPK17656341-38-9In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACZRWI458 route product structure diagram
    ACZRWI458557093-46-6In Stock
Inquiry

3. ACZRWI458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZRWI458 route product structure diagram
    ACZRWI458557093-46-6In Stock
Inquiry

Comments (0)